Found: 32
Select item for more details and to access through your institution.
Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2024, v. 13, n. 6, p. 501, doi. 10.1093/ehjacc/zuae019
- By:
- Publication type:
- Article
Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1170, doi. 10.1164/rccm.202312-2343LE
- By:
- Publication type:
- Article
Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Postpulmonary Embolism Follow-Up and Epidemiology of Chronic Thromboembolic Pulmonary Hypertension.
- Published in:
- Advances in Pulmonary Hypertension, 2022, v. 21, n. 3, p. 60, doi. 10.21693/1933-088X-21.3.60
- By:
- Publication type:
- Article
Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12134
- By:
- Publication type:
- Article
Navigating Advances in the Treatment of Pulmonary Arterial Hypertension: Understanding Multidisciplinary Approaches to Optimize Outcomes.
- Published in:
- Journal of Managed Care Medicine, 2022, v. 25, n. 2, p. 41
- By:
- Publication type:
- Article
Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension.
- Published in:
- 2021
- By:
- Publication type:
- letter
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2021, v. 11, n. 4, p. 1, doi. 10.1177/20458940211057071
- By:
- Publication type:
- Article
NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study.
- Published in:
- Pulmonary Circulation, 2021, v. 11, n. 2, p. 1, doi. 10.1177/20458940211011329
- By:
- Publication type:
- Article
Free-Floating Right Atrial Thrombus Removed by Aspiration Thrombectomy under Transesophageal Guidance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Unilateral Chronic Thromboembolic Pulmonary Disease: A Mimic of Pulmonary Artery Agenesis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update.
- Published in:
- Drug, Healthcare & Patient Safety, 2019, v. 11, p. 71, doi. 10.2147/DHPS.S173050
- By:
- Publication type:
- Article
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193226
- By:
- Publication type:
- Article
Quantifying the learning curve for pulmonary thromboendarterectomy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
- Published in:
- European Heart Journal, 2017, v. 38, n. 15, p. 1147, doi. 10.1093/eurheartj/ehx025
- By:
- Publication type:
- Article
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 498, doi. 10.1086/688489
- By:
- Publication type:
- Article
Electric Plasma-generated Nitric Oxide: Hemodynamic Effects in Patients with Pulmonary Hypertension.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of macitentan for the treatment of pulmonary arterial hypertension.
- Published in:
- Annals of the New York Academy of Sciences, 2015, v. 1358, n. 1, p. 68, doi. 10.1111/nyas.12856
- By:
- Publication type:
- Article
Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Pulmonary Artery Filling Defects: Are They All the Same?
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Chronic Thromboembolic Pulmonary Hypertension: Current Care.
- Published in:
- Advances in Pulmonary Hypertension, 2014, v. 12, n. 4, p. 162
- By:
- Publication type:
- Article
Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension.
- Published in:
- Advances in Pulmonary Hypertension, 2014, v. 12, n. 4, p. 193, doi. 10.21693/1933-088x-12.4.193
- By:
- Publication type:
- Article
Pulmonary hypertension in patients with chronic and end-stage kidney disease.
- Published in:
- Kidney International, 2013, v. 84, n. 4, p. 682, doi. 10.1038/ki.2013.186
- By:
- Publication type:
- Article
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2013, v. 3, n. 2, p. 369, doi. 10.4103/2045-8932.110445
- By:
- Publication type:
- Article
A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost.
- Published in:
- Pulmonary Circulation, 2013, v. 3, n. 2, p. 381, doi. 10.4103/2045-8932.114768
- By:
- Publication type:
- Article
Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension.
- Published in:
- Cardiovascular Therapeutics, 2013, v. 31, n. 1, p. 38, doi. 10.1111/1755-5922.12008
- By:
- Publication type:
- Article
Inhaled treprostinil: a therapeutic review.
- Published in:
- Drug Design, Development & Therapy, 2012, v. 6, p. 19, doi. 10.2147/DDDT.S19281
- By:
- Publication type:
- Article
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2006, v. 174, n. 11, p. 1257, doi. 10.1164/rccm.200603-358OC
- By:
- Publication type:
- Article
Book Notes.
- Published in:
- 2000
- By:
- Publication type:
- Book Review